While randomized controlled trials are the gold standard for evaluating drug safety and efficacy, observational studies have become increasingly important in recent years to generate real world data on burden of illness, treatment patterns, health care resource utilization, safety outcomes, treatment effectiveness, adherence, and health-related quality of life among other things. This presentation will explore these differences as well as synergies and lessons learned that could benefit scientists engaged in both clinical and observational research.
